EURURO Vol. 72 No. 6

986

Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms

G. Magistro, C.R. Chapple, M. Elhilali, P. Gilling, K.T. McVary, C.G. Roehrborn, C.G. Stief,

H.H. Woo, C. Gratzke

Initial promising clinical results on novel minimally invasive treatment options

indicate efficacy comparable to standard techniques, often associated with a more

favourable safety profile, in particular with preservation of sexual function.

998

One Strategy Does Not Fit All: The Era of Personalised Medicine for the Treatment of Male Lower Urinary Tract Symptoms Is upon Us

R.L. Tregunna, P. Cathcart, M.F. Bultitude

1000

Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores

G. Corona, G. Rastrelli, A. Morgentaler, A. Sforza, E. Mannucci, M. Maggi

The present meta-analysis investigates the effect of testosterone treatment (TTh)

on sexual function over placebo considering the International Index of Erectile

Function (IIEF) as final outcome. Our data indicate that TTh significantly improves

erectile function and other sexual parameters as measured by IIEF. The effects

of TTh on erectile dysfunction are greater in patients with lower testosterone levels

at baseline and lower in the presence of metabolic derangements, such as diabetes

and obesity. The observed mean 2.3-point increase in IIEF-erectile function domain

score is clinically meaningful, suggesting that TTh alone may be a reasonable

treatment option in men with milder form of erectile dysfunction whereas the

addition of other treatments, such as phosphodiesterase type 5 inhibitors, may be

more appropriate for men with more severe erectile dysfunction.

1012

Is a Normal Testosterone Level Necessary for Erectile Function?

T.P. Kohn, R. Ramasamy

1014

Zero-fragment Nephrolithotomy: A Multi-center Evaluation of Robotic Pyelolithotomy and Nephrolithotomy for Treating Renal Stones

R. Swearingen, A. Sood, R. Madi, Z. Klaassen, K. Badani, J..S. Elder, K. Wood, A. Hemal,

K.R. Ghani

Robotic pyelolithotomy and robotic nephrolithotomy are safe and reasonable

alternatives to percutaneous nephrolithotomy for removing renal stones in select

patients. In particular, robotic pyelolithotomy allows the removal of stones without

transgressing the parenchyma, reducing potential bleeding and nephron loss.

1022

Re: Comprehensive Qualitative Assessment of Urethral Stricture Disease: Toward the Development of a Patient Centered Outcome Measure

S.P. Elliott

1023

Re: The Use of Apnea During Ureteroscopy

P. Meria

1023

Re: Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-term Oncologic Outcomes in a Shared Equal-access Health System

T. Gasser

1024

Re: Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus

V.B. Matveev, M.I. Volkova

1025

Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy

D. D’Andrea, S.F. Shariat

1026

Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer

Y. Ohno

e u r o p e a n u r o l o g y , vo l . 7 2 , n o . 6 , D e c emb e r 2 0 1 7

Andrology

Benign Prostatic

Hyperplasia

Surgery in Motion

Words ofWisdom